Skye Bioscience, Inc. (SKYE)

Skye Bioscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	18.44	68.42	1.26	1.24	8.98	2.47
Short-Term Investments	16.87	-	-	0.07	-	-
Cash & Short-Term Investments	35.31	68.42	1.26	1.32	8.98	2.47
Cash Growth	-47.62%	5345.15%	-4.72%	-85.32%	263.77%	34.94%
Other Receivables	-	0.01	0.7	0.18	-	-
Receivables	-	0.01	0.7	0.18	-	-
Prepaid Expenses	3.71	0.2	0.19	0.78	0.57	0.19
Restricted Cash	-	-	9.08	0	0	0
Other Current Assets	0.9	2.2	0.42	6.66	0.06	0
Total Current Assets	39.92	70.83	11.65	8.94	9.61	2.66
Property, Plant & Equipment	1.35	1.88	0.28	0.16	0.23	0.01
Other Long-Term Assets	0.05	0.05	0.01	0.01	0.01	-
Total Assets	41.32	72.76	11.94	9.11	9.86	2.67
Accounts Payable	2.83	0.57	0.96	1.79	0.9	0.36
Accrued Expenses	0.92	1.77	2.06	1.12	0.9	0.32
Short-Term Debt	-	-	4.37	0.06	-	-
Current Portion of Long-Term Debt	-	-	-	1.85	1.97	0.06
Current Portion of Leases	0.2	0.18	0.07	0.08	0.08	-
Other Current Liabilities	4.42	1.82	6.44	7.22	0.06	0.04
Total Current Liabilities	8.37	4.34	13.9	12.12	3.91	0.79
Long-Term Debt	-	-	-	-	-	1.43
Long-Term Leases	0.12	0.27	0.17	-	0.08	-
Total Liabilities	8.49	4.61	14.07	12.12	3.99	2.22
Common Stock	0.03	0.03	0.01	0	0.48	0.29
Additional Paid-In Capital	205.24	199.07	102.24	63.73	52.64	38.9
Retained Earnings	-172.43	-130.95	-104.38	-66.74	-47.26	-38.73
Total Common Equity	32.84	68.15	-2.13	-3.01	5.86	0.45
Shareholders' Equity	32.84	68.15	-2.13	-3.01	5.86	0.45
Total Liabilities & Equity	41.32	72.76	11.94	9.11	9.86	2.67
Total Debt	0.32	0.46	4.62	1.98	2.14	1.5
Net Cash (Debt)	34.99	67.96	-3.36	-0.66	6.85	0.97
Net Cash Growth	-47.95%	-	-	-	604.71%	-32.66%
Net Cash Per Share	0.88	1.86	-0.48	-0.30	4.21	1.05
Filing Date Shares Outstanding	32.06	30.97	28.06	3.89	1.98	1.4
Total Common Shares Outstanding	30.99	30.97	12.35	3.65	1.9	1.15
Working Capital	31.56	66.49	-2.25	-3.18	5.7	1.88
Book Value Per Share	1.06	2.20	-0.17	-0.82	3.08	0.39
Tangible Book Value	32.84	68.15	-2.13	-3.01	5.86	0.45
Tangible Book Value Per Share	1.06	2.20	-0.17	-0.82	3.08	0.39
Machinery	-	1.64	0.12	-	-	-
Leasehold Improvements	-	0.02	0.01	-	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q